Skip to content

Revvity

US · RVTY #1032 by market cap Listed 1970
145.22 -6.37 -4.20%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Revvity

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.

Founded
1937
CEO
Dr. Prahlad R. Singh, PhD
Employees
11,000
Headquarters
Waltham, Massachusetts, United States of America
Fiscal year end
12-27
Website
revvity.com

Company profile

Exchange
US
Symbol
RVTY
Market-cap rank
#1032
Listing date
1970-01-01
Market cap
16.21B
Float cap
16.13B
Shares out
111.64M
Float shares
111.07M

Sectors & themes

Diagnostics & Research Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Revvity discussion 0 comments

Add a comment